Skip to search formSkip to main contentSkip to account menu

Falimarev

Known as: rFowlpox-CEA(D609)/MUC1(L93)/TRICOM Vaccine, Fowlpox-CEA(D609)-MUC1(L93)-TRICOM Vaccine, fowlpox-CEA-MUC-1-TRICOM vaccine 
A cancer vaccine comprised of a recombinant fowlpox viral vector encoding the carcinoembryonic antigen (CEA), MUC-1, a transmembrane glycoprotein… 
National Institutes of Health

Related topics

Related topics

6 relations
Carcinoembryonic AntigenCytotoxic T-LymphocytesGene Expression RegulationMucin-1 Antigen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2008
2008
Gateways to clinical trials.
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following… 
2006
2006
Randomized single institute pilot study of vaccinia-CEA(6D)-tricom and fowlpox-CEA (6D)-tricom with GM-CSF (V) in combination with docetaxel (D) in patients with colorectal cancer (CC).
13538 Background: Our previous study demonstrated 40% patients with CC achieved stable disease at 4 months with V (JCO, 23(4):720… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)